Thu, March 23, 2023
Wed, March 22, 2023
Tue, March 21, 2023
Mon, March 20, 2023
Sat, March 18, 2023
Fri, March 17, 2023
Thu, March 16, 2023
Wed, March 15, 2023

Julio Romero Maintained (ACAD) at Hold with Increased Target to $21 on, Mar 20th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-21-on-mar-20th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Julio Romero of JP Morgan, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Hold with Increased Target from $19 to $21 on, Mar 20th, 2023.

Julio has made no other calls on ACAD in the last 4 months.



There are 11 other peers that have a rating on ACAD. Out of the 11 peers that are also analyzing ACAD, 6 agree with Julio's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Increased Target to $20 on, Tuesday, March 14th, 2023
  • Neena Bitritto-Garg of "Citigroup" Maintained at Hold with Increased Target to $21 on, Tuesday, March 14th, 2023
  • Tazeen Ahmad of "B of A Securities" Maintained at Hold and Held Target at $23 on, Tuesday, March 14th, 2023
  • Uy Ear of "Mizuho" Reiterated at Hold and Held Target at $19 on, Monday, March 13th, 2023
  • Jay Olson of "Oppenheimer" Maintained at Hold with Increased Target to $20 on, Wednesday, March 1st, 2023
  • Jason West of "JMP Securities" Maintained at Hold with Decreased Target to $22 on, Tuesday, February 28th, 2023


These are the ratings of the 5 analyists that currently disagree with Julio


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $28 on, Tuesday, March 14th, 2023
  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $33 on, Tuesday, March 14th, 2023
  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $27 on, Tuesday, March 14th, 2023
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $26 on, Tuesday, March 14th, 2023
  • Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $22 on, Tuesday, January 3rd, 2023

Publication Contributing Sources